Dr. John Cush RheumNow
4 years 10 months ago
Sick Leave and Work Disability in Patients with AxSpA: Dr. Mrinalini Dey ( @DrMiniDey) discusses abstracts #0380 and #0381 presented at the #ACR21 annual meeting.
https://t.co/Wm4qpxerYJ https://t.co/6CwPrZjqJT
Uveitis is the most frequent extra-musculoskeletal manifestation (EAM) in Axial Spondyloarthritis (axSpA). The prevalence of uveitis in axSpA is between 25-30%. Up to 50% of patients with an acute episode of uveitis develop recurrent anterior uveitis or iritis. Being such a prevalent EAM in axSpA, we should focus on this condition. There have been some updates on uveitis in SpA at #ACR21 which I will share here.
Dr. John Cush RheumNow
4 years 10 months ago
The Influence of Obesity on Choice of Biologic Agent in Rheumatoid Arthritis
Dr. Richard Conway ( @RichardPAConway) reviews an abstract presented at #ACR21.
https://t.co/PkJmpODz8v https://t.co/zuJjofka3B
Dr. John Cush RheumNow
4 years 10 months ago
RheumNow’s expanded coverage of #ACR21 meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its Faculty.
The third day of ACR 2021 took a big leap in online content. Here is a compilation (with links) of presentations were the “ACRBest” as seen by our RheumNow faculty.
